Biotech

All Articles

Novartis sparks brand new stage of Voyager contract with $15M capsid offer

.Novartis is opening a new frontier in its partnership with Voyager Therapeutics, paying $15 thousan...

Lilly blog posts more favorable records on its own once a week the hormone insulin possibility

.On the heels of an FDA turndown for its own main competing Novo Nordisk, Eli Lilly is actually pick...

IN 8bio halts phase 2 test, lays off half of workforce

.Merely a few months after dosing the initial individual in a period 2 test for recently diagnosed g...

Lilly, Haya ink $1B biobuck excessive weight treaty to search dark genome

.Eli Lilly's hunt for obesity intendeds has actually led it to the black genome. The Big Pharma has ...

ArsenalBio raises $325M, turns away from previous lead resource

.Collection Biosciences is actually moving on up. The tissue therapy company has added $325 million ...

Lilly- supported weight loss biotech documents IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to de...

Aelis' cannabis usage medication fails period 2b, driving Indivior to reassess $100M possibility

.Aelis Farma's chances of safeguarding a fast, good choice on a $100 million option remittance have ...

ProKidney stops stage 3 test not required for cell treatment approval

.ProKidney has stopped some of a set of phase 3 tests for its cell therapy for kidney condition afte...

Vaxcyte surges on 'spectacular' 31-valent PCV gain versus Pfizer

.Vaxcyte introduced what professionals named "spectacular" phase 1/2 information for its 31-valent p...

Recursion's brain condition test reveals insufficient documentation of efficiency

.Recursion has stumbled through a very early test of its tech-enabled strategy to medication discove...